dry mouth from tirzepatide on Mounjaro: Causes, Management & Alternatives Managing Dry Mouth While on

Given the potential for significant health improvements with semaglutide GLP-1 use, many find the investment worthwhile, as it may help in avoiding more expensive medical treatments in the future

Novo Nordisks next-generation obesity candidate CagriSema did not meet its primary endpoint of non-inferiority when compared head-to-head with tirzepatide from Eli Lilly, marketed as Zepbound and Mounjaro

These finding suggest that Clostridia bacteria have potential as a biomarker for bile acid diarrhea or IBS-D and as a target for therapy

Routine liver function monitoring is not mandated for patients with normal baseline results and no risk factors

For newly diagnosed type 2 diabetes patients, current ADA guidelines support initial combination therapy when A1c is 1.5% above target

And then what's the baseline